Summary
The European health care system is moving toward personalised, distributed, and home-based services. This is made possible via new and improved connected medical devices (MDs) and in vitro diagnostic devices connected to the internet (together, CMDs), and will benefit health care providers in terms of reduced cost (fewer hospital beds) and improved service. Patients will see improved quality of life in terms of reduced travel time and reduced stress via treatment at home or where they want it. However, for these benefits to be fully realised, the cybersecurity of CMDs needs to be ensured.
NEMECYS will benefit practitioners such as cybersecurity communities, MD manufacturers, CMD scenario system integrators and CMD scenario operators (e.g. health care providers), with downstream benefits to patients and the wider public, through more cost-effective and efficient care enabled via effective and streamlined cybersecurity.
NEMECYS helps practitioners to (1) comply with MD regulations; (2) to be able to apply proportionate MD cybersecurity (too little security risks exposure, too much is costly and can obstruct clinical care) and (3) build in cybersecurity by design for both MDs and the connected scenarios they operate in. This is achieved by (1) providing recommendations for best practice and guidelines for MD cybersecurity by design, along with compliance assurance tooling; (2) providing a risk-benefit scheme to address cybersecurity risk balanced with clinical benefit; and (3) providing a set of specific tools to address MD cybersecurity by design and their deployment in connected scenarios.
The NEMECYS team has cybersecurity risk experts, two hospitals who are already implementing IoT and remote care-based scenarios, three medical device manufacturers, major computer science research players and experienced systems integrators. This team is ideally placed to ensure that NEMECYS can enable practitioners to apply the right security at the right place, at low cost.
NEMECYS will benefit practitioners such as cybersecurity communities, MD manufacturers, CMD scenario system integrators and CMD scenario operators (e.g. health care providers), with downstream benefits to patients and the wider public, through more cost-effective and efficient care enabled via effective and streamlined cybersecurity.
NEMECYS helps practitioners to (1) comply with MD regulations; (2) to be able to apply proportionate MD cybersecurity (too little security risks exposure, too much is costly and can obstruct clinical care) and (3) build in cybersecurity by design for both MDs and the connected scenarios they operate in. This is achieved by (1) providing recommendations for best practice and guidelines for MD cybersecurity by design, along with compliance assurance tooling; (2) providing a risk-benefit scheme to address cybersecurity risk balanced with clinical benefit; and (3) providing a set of specific tools to address MD cybersecurity by design and their deployment in connected scenarios.
The NEMECYS team has cybersecurity risk experts, two hospitals who are already implementing IoT and remote care-based scenarios, three medical device manufacturers, major computer science research players and experienced systems integrators. This team is ideally placed to ensure that NEMECYS can enable practitioners to apply the right security at the right place, at low cost.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/101094323 |
| Start date: | 01-01-2023 |
| End date: | 31-12-2025 |
| Total budget - Public funding: | 4 208 360,00 Euro - 4 208 360,00 Euro |
Cordis data
Original description
The European health care system is moving toward personalised, distributed, and home-based services. This is made possible via new and improved connected medical devices (MDs) and in vitro diagnostic devices connected to the internet (together, CMDs), and will benefit health care providers in terms of reduced cost (fewer hospital beds) and improved service. Patients will see improved quality of life in terms of reduced travel time and reduced stress via treatment at home or where they want it. However, for these benefits to be fully realised, the cybersecurity of CMDs needs to be ensured.NEMECYS will benefit practitioners such as cybersecurity communities, MD manufacturers, CMD scenario system integrators and CMD scenario operators (e.g. health care providers), with downstream benefits to patients and the wider public, through more cost-effective and efficient care enabled via effective and streamlined cybersecurity.
NEMECYS helps practitioners to (1) comply with MD regulations; (2) to be able to apply proportionate MD cybersecurity (too little security risks exposure, too much is costly and can obstruct clinical care) and (3) build in cybersecurity by design for both MDs and the connected scenarios they operate in. This is achieved by (1) providing recommendations for best practice and guidelines for MD cybersecurity by design, along with compliance assurance tooling; (2) providing a risk-benefit scheme to address cybersecurity risk balanced with clinical benefit; and (3) providing a set of specific tools to address MD cybersecurity by design and their deployment in connected scenarios.
The NEMECYS team has cybersecurity risk experts, two hospitals who are already implementing IoT and remote care-based scenarios, three medical device manufacturers, major computer science research players and experienced systems integrators. This team is ideally placed to ensure that NEMECYS can enable practitioners to apply the right security at the right place, at low cost.
Status
SIGNEDCall topic
HORIZON-HLTH-2022-IND-13-01Update Date
09-02-2023
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Search
Organisations
-
| SINTEF AS (SINTEF) (Coördinator)
-
| Athens Technology Center SA
-
| BD SWITZERLAND SARL
-
| DEBIOTECH S.A.
-
| IBM ISRAEL - SCIENCE AND TECHNOLOGY LTD
-
| INFORMATION CATALYST FOR ENTERPRISE LTD
-
| INFORMATION CATALYST SL (ICE-ES)
-
| MARINA SALUD SA
-
| MODE SENSORS AS
-
| OSPEDALE SAN RAFFAELE SRL
-
| PANEPISTIMIO IOANNINON
-
| PD NEUROTECHNOLOGY LTD
-
| RIBERA SALUD TECNOLOGIAS SOCIEDAD LIMITADA
-
| UNIVERSITY OF SOUTHAMPTON